Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) EPS (Weighted Average and Diluted) (2017 - 2025)

Historic EPS (Weighted Average and Diluted) for Arrowhead Pharmaceuticals (ARWR) over the last 12 years, with Q4 2025 value amounting to $0.22.

  • Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) rose 11582.73% to $0.22 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.53, marking a year-over-year increase of 12965.12%. This contributed to the annual value of $0.23 for FY2025, which is 10442.32% up from last year.
  • As of Q4 2025, Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $0.22, which was up 11582.73% from $0.12 recorded in Q3 2025.
  • Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted)'s 5-year high stood at $2.75 during Q1 2025, with a 5-year trough of -$1.45 in Q3 2024.
  • Over the past 5 years, Arrowhead Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$0.65 (recorded in 2022), while the average stood at -$0.47.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 32666.67% in 2024, then skyrocketed by 36960.78% in 2025.
  • Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.6 in 2021, then soared by 35.0% to -$0.39 in 2022, then plummeted by 217.95% to -$1.24 in 2023, then dropped by 12.1% to -$1.39 in 2024, then soared by 115.83% to $0.22 in 2025.
  • Its last three reported values are $0.22 in Q4 2025, $0.12 for Q3 2025, and -$1.26 during Q2 2025.